Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TWST Twist Bioscience Corp

未开盘 11-09 16:00:00 EST

135.34

+14.55

+12.05%

盘后135.80

+0.46+0.34%

19:42 EST

最高138.30	最低121.24	成交量166.99万
今开123.80	昨收120.79	日振幅14.13%
总市值89.10亿	流通市值87.50亿	总股本6,583万
成交额2.24亿	换手率2.58%	流通股本6,465万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TWST","market":"US","secType":"STK","nameCN":"Twist Bioscience Corp","latestPrice":135.34,"timestamp":1794258000000,"preClose":120.79,"halted":0,"volume":1669949,"hourTrading":{"tag":"盘后","latestPrice":135.8,"preClose":135.34,"latestTime":"19:42 EST","volume":38754,"amount":5245528.1476,"timestamp":1794271371294,"change":0.46,"changeRate":0.003399,"amplitude":0.00495},"delay":0,"changeRate":0.120456991472804,"floatShares":64654475,"shares":65832424,"eps":-2.229262,"marketStatus":"未开盘","change":14.55,"latestTime":"11-09 16:00:00 EST","open":123.8,"high":138.3,"low":121.235,"amount":223744910.46292,"amplitude":0.141278,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.229262,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794301200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1540958400000,"exchange":"NASDAQ","adjPreClose":120.79,"preHourTrading":{"tag":"盘前","latestPrice":124.36,"preClose":120.79,"latestTime":"09:29 EST","volume":2076,"amount":255534.25872,"timestamp":1794234599999,"change":3.57,"changeRate":0.029555,"amplitude":0.049673},"postHourTrading":{"tag":"盘后","latestPrice":135.8,"preClose":135.34,"latestTime":"19:42 EST","volume":38754,"amount":5245528.1476,"timestamp":1794271371294,"change":0.46,"changeRate":0.003399,"amplitude":0.00495},"volumeRatio":0.709456,"optionData":{"bulkOrders":[{"symbol":"TWST","call":true,"expireDate":1795150800000,"strike":"150.0","timestamp":1794245254924,"price":8.05,"volume":1103,"amount":887915,"type":"-"},{"symbol":"TWST","call":true,"expireDate":1795150800000,"strike":"140.0","timestamp":1794245254924,"price":11.85,"volume":1103,"amount":1307055,"type":"+"}]},"impliedVol":1.2021,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/TWST","defaultTab":"news","newsList":[{"id":"1198393279","title":"异动解读｜Twist Bioscience Corp盘中上涨6.19%，财报预期与合作催化持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1198393279","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198393279?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:40","pubTimestamp":1794235202,"startTime":"0","endTime":"0","summary":"11月9日，Twist Bioscience Corp盘中上涨6.19%，报128.94美元/股，成交额1194.71万美元。消息面上，市场仍在围绕公司近期财报一致预期、AI药物发现相关大单预期，以及与礼来TuneLab合作进展进行交易，资金博弈延续。目前市场预计公司本季度营收约1.23亿美元，同比增长25.96%，调整后每股收益预期为-0.37美元至-0.44美元，亏损收窄趋势受到关注；此前公司已宣布为礼来TuneLab提供抗体表征数据服务，叠加AIDD方向订单增长预期，带动股价波动放大。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience大涨，礼来合作与AI订单催化发酵","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161167331","title":"异动解读｜Twist Bioscience Corp盘中上涨6.81%，财报预期升温下资金博弈加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1161167331","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161167331?lang=zh_cn&edition=full","pubTime":"2026-11-06 22:55","pubTimestamp":1793976953,"startTime":"0","endTime":"0","summary":"11月6日，Twist Bioscience Corp盘中上涨6.81%，报129.43美元/股，成交额3209.84万美元。消息面上，市场仍在围绕公司11月12日财报前的一致预期与前期催化进行交易，短线资金博弈加剧。当前市场预计公司本季度营收约1.23亿美元，同比增长25.96%，调整后每股收益预期为-0.37美元，亏损收窄趋势延续；同时，前期AIDD大单预期、与礼来TuneLab合作，以及投行中性评级带来的交易热度仍在消化，推动股价波动放大。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报预期升温，Twist Bioscience盘中拉升","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109526631","title":"异动解读｜Twist Bioscience Corp盘中下跌5.58%，财报预期升温下资金博弈加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1109526631","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109526631?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:39","pubTimestamp":1793889583,"startTime":"0","endTime":"0","summary":"11月5日，Twist Bioscience Corp盘中下跌5.58%，报129.5525美元/股，成交额1427.6万美元。消息面上，市场正消化公司11月12日财报前的一致预期与前期催化，短线资金博弈加剧。当前市场预计公司本季度营收约1.23亿美元，同比增长25.96%，调整后每股收益预计为-0.37美元，亏损收窄趋势延续；但前期AIDD大单预期、与礼来TuneLab合作及投行中性评级带来的交易热度仍在消化中，股价波动放大。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前夜股价下跌，Twist Bioscience资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112243520","title":"异动解读｜Twist Bioscience Corp盘前下跌5.15%，财报预期升温下资金博弈加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1112243520","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112243520?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:26","pubTimestamp":1793888813,"startTime":"0","endTime":"0","summary":"11月5日，Twist Bioscience Corp盘前下跌5.15%，报133.01美元/股，成交额67.21万美元。消息面上，公司将于11月12日公布最新季度财报，市场一致预期本季度营收约1.23亿美元，同比增长25.96%，调整后每股收益预计为-0.37美元，亏损收窄趋势延续；但在财报前窗口，资金对前期AIDD大单、礼来TuneLab合作及投行中性评级的消化仍在继续，短线博弈加剧，股价波动放大。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报临近，Twist Bioscience盘前下挫","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119804919","title":"财报前瞻 | Twist Bioscience Corp本季度营收预计增25.96%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1119804919","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119804919?lang=zh_cn&edition=full","pubTime":"2026-11-05 08:17","pubTimestamp":1793837839,"startTime":"0","endTime":"0","summary":"Twist Bioscience Corp将于2026年11月12日公布最新季度财报，本文梳理市场一致预期、上季度表现与关键业务动向，并结合近期研判给出核心看点。市场一致预期显示，本季度Twist Bioscience Corp营收预计为1.23亿美元，同比增长25.96%；调整后每股收益预计为-0.37美元，同比增长13.96%；息税前利润预计为-2,327.76万美元，同比增长19.88%。季度内公司维持高毛利率结构并推动费用效率优化，亏损率收窄趋势延续。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | Twist Bioscience Corp本季度营收预计增25.96%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159140803","title":"异动解读｜Twist Bioscience Corp盘中下跌5.34%，投行评级与礼来合作催化后资金波动加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1159140803","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159140803?lang=zh_cn&edition=full","pubTime":"2026-11-04 23:46","pubTimestamp":1793807184,"startTime":"0","endTime":"0","summary":"11月4日，Twist Bioscience Corp盘中下跌5.34%，报134.05美元/股，成交额5981.7万美元。消息面上，市场仍在消化公司近期获得投行覆盖及与礼来旗下TuneLab合作的进展，但公开信息未见更强新增催化，资金博弈有所加剧。此前，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；公司还宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务，合作方向聚焦抗体药物发现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bio盘中下挫，投行评级与礼来合作后资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157199524","title":"异动解读｜Twist Bioscience Corp盘中上涨5.9%，AIDD大单预期支撑资金回流","url":"https://stock-news.laohu8.com/highlight/detail?id=1157199524","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157199524?lang=zh_cn&edition=full","pubTime":"2026-11-03 22:37","pubTimestamp":1793716669,"startTime":"0","endTime":"0","summary":"11月3日，Twist Bioscience Corp盘中上涨5.9%，报138.89美元/股，成交额2402.2万美元。消息面上，市场继续交易公司在AI药物发现领域的大额订单预期。公开信息显示，AIDD已成为公司重要增量来源，相关单笔采购订单被称为公司历史上金额最大的订单，强化了市场对其中期需求扩张的关注。多重催化叠加下，股价短线波动加大。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience上涨，AIDD大单预期升温","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157610632","title":"异动解读｜Twist Bioscience Corp盘中下跌5.51%，投行评级与礼来合作催化后资金波动加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1157610632","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157610632?lang=zh_cn&edition=full","pubTime":"2026-11-02 23:08","pubTimestamp":1793632139,"startTime":"0","endTime":"0","summary":"11月2日，Twist Bioscience Corp盘中下跌5.51%，报144.36美元/股，成交额4124.84万美元。消息面上，市场仍在消化公司近期获得投行覆盖及与礼来旗下TuneLab合作的进展，但公开信息更多反映前期关注度提升，未见更强新增催化，资金博弈有所加剧。此前，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；公司还宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务，合作方向聚焦抗体药物发现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中走低，投行评级与礼来合作后资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195337562","title":"异动解读｜Twist Bioscience Corp盘中下跌6.31%，投行评级与礼来合作催化后资金波动加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1195337562","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195337562?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:46","pubTimestamp":1793368006,"startTime":"0","endTime":"0","summary":"10月30日，Twist Bioscience Corp盘中下跌6.31%，报161.96美元/股，成交额5031.38万美元。消息面上，市场仍在消化公司近期获得投行覆盖及与礼来旗下TuneLab合作的进展，但最新公开信息更多反映前期关注度提升，未见更强新增催化，资金博弈加剧。此前，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；公司还宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务，合作方向聚焦抗体药物发现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中下挫，投行评级后资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193336267","title":"异动解读｜Twist Bioscience Corp盘前下跌6.05%，投行评级与礼来合作催化后资金波动加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1193336267","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193336267?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:16","pubTimestamp":1793348202,"startTime":"0","endTime":"0","summary":"10月30日，Twist Bioscience Corp盘前下跌6.05%，报161.3美元/股，成交额14.59万美元。消息面上，市场仍在消化公司近期获得投行覆盖及与礼来旗下TuneLab合作的进展，但最新公开信息更多反映前期关注度提升，未见更强新增催化，资金博弈加剧。此前，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；公司还宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务，合作方向聚焦抗体药物发现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘前下跌，投行评级后资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171732544","title":"异动解读｜Twist Bioscience Corp夜盘下跌6.09%，投行评级与礼来合作催化后资金波动加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1171732544","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171732544?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:04","pubTimestamp":1793318699,"startTime":"0","endTime":"0","summary":"10月30日，Twist Bioscience Corp夜盘下跌6.09%，报164.47美元/股，成交额5594.66美元。消息面上，市场仍在消化公司近期获得投行覆盖及与礼来旗下TuneLab合作的进展，但最新公开信息主要体现为前期关注度提升，未见更强新增催化，资金博弈加剧。此前，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；公司还宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务，合作方向聚焦抗体药物发现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist夜盘走低，资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111841427","title":"异动解读｜Twist Bioscience Corp盘后下跌6.31%，投行评级与礼来合作催化后资金波动加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1111841427","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111841427?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:15","pubTimestamp":1793308502,"startTime":"0","endTime":"0","summary":"10月30日，Twist Bioscience Corp盘后下跌6.31%，报162.5美元/股，成交额434.74万美元。消息面上，市场仍在消化公司近期获得投行覆盖及与礼来旗下TuneLab合作的进展，但最新公开信息主要体现为前期关注度提升，未见更强新增催化。此前，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；公司还宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务，合作方向聚焦抗体药物发现。Twist Bioscience Corporation于2013年2月4日在特拉华州注册成立。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘后下跌，礼来合作后资金博弈加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163421565","title":"异动解读｜Twist Bioscience Corp盘中上涨5.55%，投行评级与礼来合作进展支撑关注度","url":"https://stock-news.laohu8.com/highlight/detail?id=1163421565","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163421565?lang=zh_cn&edition=full","pubTime":"2026-10-28 21:40","pubTimestamp":1793194855,"startTime":"0","endTime":"0","summary":"10月28日，Twist Bioscience Corp盘中上涨5.55%，报168.715美元/股，成交额3240.75万美元。消息面上，公司近期获得投行覆盖，且此前披露与礼来旗下TuneLab达成抗体药物发现相关合作，持续提升市场关注度。公开信息显示，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；同时，公司此前宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务，资金对其AI赋能药物研发的关注仍在延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中上涨，礼来合作与投行评级引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164467170","title":"异动解读｜Twist Bioscience Corp盘中上涨5.14%，投行评级与礼来合作进展支撑关注度","url":"https://stock-news.laohu8.com/highlight/detail?id=1164467170","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164467170?lang=zh_cn&edition=full","pubTime":"2026-10-27 21:54","pubTimestamp":1793109290,"startTime":"0","endTime":"0","summary":"10月27日，Twist Bioscience Corp盘中上涨5.14%，报152.71美元/股，成交额2512.58万美元。消息面上，公司近期先后获得投行覆盖，并在此前披露与礼来旗下TuneLab达成抗体药物发现相关合作，持续提升市场关注度。公开信息显示，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；同时，公司此前宣布向礼来TuneLab这一AI／ML药物发现平台提供抗体表征数据服务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中上涨，礼来合作引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198025896","title":"异动解读｜Twist Bioscience Corp盘中上涨5.27%，投行评级与合作进展支撑关注度","url":"https://stock-news.laohu8.com/highlight/detail?id=1198025896","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198025896?lang=zh_cn&edition=full","pubTime":"2026-10-26 23:32","pubTimestamp":1793028770,"startTime":"0","endTime":"0","summary":"10月26日，Twist Bioscience Corp盘中上涨5.27%，报147.5595美元/股，成交额5699.68万美元。消息面上，公司近期先后获得投行覆盖，并在此前披露与礼来旗下TuneLab达成抗体药物发现合作，持续提升市场关注度。此前Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价；同时，公司于9月宣布向礼来TuneLab提供抗体表征数据服务。多项公开信息叠加下，资金对其AI赋能药物研发与估值预期的博弈仍在延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中上涨，礼来合作与投行评级提振关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140818495","title":"异动解读｜Twist Bioscience Corp盘中下跌5.08%，持股变动披露后资金关注波动延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1140818495","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140818495?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:24","pubTimestamp":1792679078,"startTime":"0","endTime":"0","summary":"10月22日，Twist Bioscience Corp盘中下跌5.08%，报141.555美元/股，成交额6945.64万美元。消息面上，公司此前披露持股变动声明，涉及Laponis Adam，相关事项已连续成为市场关注的公开事件催化。从背景看，该股此前已因同一事件出现明显波动，盘前一度下跌5.85%，夜盘跌5.1%，更早前盘中曾上涨5.16%；同时，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价，显示市场对其短期估值分歧仍在，本次回落反映持股变动披露后的资金关注与波动延续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘中走低，持股变动引发资金持续关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143622267","title":"异动解读｜Twist Bioscience Corp盘前下跌5.85%，持股变动披露后资金关注波动延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1143622267","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143622267?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:44","pubTimestamp":1792662293,"startTime":"0","endTime":"0","summary":"10月22日，Twist Bioscience Corp盘前下跌5.85%，报142.67美元/股，成交额39.11万美元。消息面上，公司此前披露持股变动声明，涉及Laponis Adam，相关事项已连续成为市场关注的公开事件催化。从背景看，该股此前已因同一事件出现明显波动，盘前一度下跌5.4%，盘中又上涨5.16%；同时，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价，反映市场对其短期估值分歧仍在。本次盘前回落，显示持股变动披露后的资金关注与波动仍在延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"持股变动持续发酵，盘前股价走低","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103274080","title":"异动解读｜Twist Bioscience Corp夜盘下跌5.1%，持股变动披露后资金关注波动延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1103274080","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103274080?lang=zh_cn&edition=full","pubTime":"2026-10-22 15:50","pubTimestamp":1792655445,"startTime":"0","endTime":"0","summary":"10月22日，Twist Bioscience Corp夜盘下跌5.1%，报141.53美元/股，成交额133.25万美元。消息面上，公司此前披露持股变动声明，涉及Laponis Adam，相关事项已连续成为市场关注的公开事件催化。从背景看，该股此前一度因同一事件出现明显波动，盘前曾下跌5.4%，盘中又上涨5.16%；同时，Jefferies给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价，显示市场对其短期估值分歧仍在。本次夜盘回落，反映持股变动披露后资金关注波动延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience夜盘走低，持股变动引发资金关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179660963","title":"异动解读｜Twist Bioscience Corp盘中上涨5.16%，持股变动披露后资金关注延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1179660963","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179660963?lang=zh_cn&edition=full","pubTime":"2026-10-21 21:48","pubTimestamp":1792590512,"startTime":"0","endTime":"0","summary":"10月21日，Twist Bioscience Corp盘中上涨5.16%，报150.07美元/股，成交额2538.67万美元。消息面上，公司此前披露持股变动声明，涉及Laponis Adam，近期连续成为市场关注的公开事件催化。从背景看，该股前一交易日曾因同一事件获得资金关注，Jefferies此前启动覆盖并给予持有评级及150美元目标价，UBS给予中性评级及144美元目标价，显示市场对其短期估值分歧仍在；本次走强反映持股变动披露后的关注度延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience股价上涨，持股变动引资金关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189237446","title":"异动解读｜Twist Bioscience Corp盘前下跌5.4%，持股变动披露后资金关注波动延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1189237446","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189237446?lang=zh_cn&edition=full","pubTime":"2026-10-21 19:08","pubTimestamp":1792580919,"startTime":"0","endTime":"0","summary":"10月21日，Twist Bioscience Corp盘前下跌5.4%，报135.0美元/股，成交额30.21万美元。消息面上，公司此前披露持股变动声明，涉及Laponis Adam，近期连续成为市场关注的公开事件催化。本次盘前回落，显示前期关注修复后股价波动延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience盘前下跌，持股变动引发资金关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.twistbioscience.com","stockEarnings":[{"period":"1week","weight":0.0488},{"period":"1month","weight":-0.153},{"period":"3month","weight":0.0993},{"period":"6month","weight":1.4883},{"period":"1year","weight":3.4711},{"period":"ytd","weight":3.2667}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.014},{"period":"1year","weight":0.1218},{"period":"ytd","weight":0.1038}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Twist Bioscience Corporation于2013年2月4日在特拉华州注册成立。该公司致力于为那些正在把世界变得更好的客户服务。在卫生保健、食品/农业、工业化学品、学术研究和数据存储等领域，客户正在利用他们的合成DNA工具开发改善生活和改善地球可持续性的方法。他们开发了一个颠覆性的DNA合成平台，使生物学工程产业化，为广泛的用途和市场提供DNA。他们将基于硅的DNA编写技术与专有软件、可伸缩的商业基础设施和电子商务平台结合起来，创建了一个集成的技术平台。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.077829},{"month":2,"riseRate":0.375,"avgChangeRate":-0.03419},{"month":3,"riseRate":0.375,"avgChangeRate":-0.060203},{"month":4,"riseRate":0.5,"avgChangeRate":-0.03729},{"month":5,"riseRate":0.75,"avgChangeRate":0.086916},{"month":6,"riseRate":1,"avgChangeRate":0.238398},{"month":7,"riseRate":0.625,"avgChangeRate":0.087317},{"month":8,"riseRate":0.25,"avgChangeRate":-0.006755},{"month":9,"riseRate":0.5,"avgChangeRate":0.016501},{"month":10,"riseRate":0.375,"avgChangeRate":-0.040108},{"month":11,"riseRate":0.555556,"avgChangeRate":0.176555},{"month":12,"riseRate":0.25,"avgChangeRate":0.020968}],"exchange":"NASDAQ","name":"Twist Bioscience Corp","nameEN":"Twist Bioscience Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Twist Bioscience Corp(TWST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Twist Bioscience Corp,TWST,Twist Bioscience Corp股票,Twist Bioscience Corp股票老虎,Twist Bioscience Corp股票老虎国际,Twist Bioscience Corp行情,Twist Bioscience Corp股票行情,Twist Bioscience Corp股价,Twist Bioscience Corp股市,Twist Bioscience Corp股票价格,Twist Bioscience Corp股票交易,Twist Bioscience Corp股票购买,Twist Bioscience Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Twist Bioscience Corp(TWST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}